Home / News / Global Carcinoembryonic Antigen (CEA) Market is Expected to Reach USD 2,787.3 Mn by 2023 – Credence Research

Global Carcinoembryonic Antigen (CEA) Market is Expected to Reach USD 2,787.3 Mn by 2023 – Credence Research

The latest market report published by Credence Research, Inc. “Global Carcinoembryonic Antigen (CEA) Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2023,” the carcinoembryonic antigen (CEA) market was valued at USD 1,624.2 Mn in 2015, and is expected to reach USD 2,787.3 Mn by 2023, expanding at a CAGR of 6.4% from 2016 to 2023.

Browse the full report Carcinoembryonic Antigen (CEA) Market – Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2023 at http://www.credenceresearch.com/report/carcinoembryonic-antigen-cea-market

Market Insights

According to Quest Diagnostics, CEA is an oncofetal glycoprotein present in the gastrointestinal tract and body fluids of the embryo and fetus. This antigen is also present in certain adult gastrointestinal cells, including the mucosal cells of the colorectum, and small amounts are present in blood. Market experts suggest that key growth drivers assisting the growth of CEA market comprises high prevalence of cancer, mounting global geriatric population base, high demand for minimally invasive diagnostic procedures in cancer and increasing application of CEA for diagnosis at several stages of cancer. In addition, a few factors that assist the overall market growth are growing healthcare expenditure which is boosting the need for efficient diagnostic procedure for cancer and influencing the usage of combination biomarkers.

The global carcinoembryonic antigen (CEA) market is segmented on the basis of application type into ovarian cancer, colorectal cancer, pancreatic cancer, lung cancer, breast cancer, thyroid cancer and other cancers. In base year 2015, colorectal cancer dominated the overall market in terms of revenue. The key factors responsible for growth of CEA market are increase in number of population consuming alcohol, sedentary lifestyle, and high intake of saturated fats in all age groups. Moreover, rising preference for CEA test in cancer diagnosis and management is expected to assist its market growth in the near future.

In base year 2015, North America was observed as the largest CEA market due to high public awareness related to early cancer diagnosis, rising preference for minimally invasive cancer diagnosis tests and sophisticated health care facilities for cancer management. Incessant technological developments followed by new discoveries of specific antigens and biomarkers are anticipated to boost the growth of CEA market testing. The key factors assisting the growth of CEA market comprises aging population, highly accessible technologically advanced healthcare facilities, successful governmental and non-governmental initiatives, and demand for precise diagnostic procedures.

Market Competition Assessment:

The carcinoembryonic antigen (CEA) market is observed as the most diversified and competitive market comprising large number of players. The market is dominated by several players, depending on their major competencies. The key players in this market are Quest Diagnostics, F. Hoffman LA Roche, Abbott Laboratories, GenWay Biotech Inc., Correlogic Systems, Inc., and Others.

Browse the full report at http://www.credenceresearch.com/report/carcinoembryonic-antigen-cea-market

Key Market Movements:

Rising prevalence of cancer is expected to drive the CEA tests market in the near future
Increasing demand for minimally invasive diagnosis methods for cancer
Growing healthcare expenditure in developing countries is assisting the growth of CEA tests
The regulatory framework for approval process has always been the most critical restraining factor in the cancer diagnosis
According to NICE, the specificity in detecting diseases is almost between 30-80% during CEA test for the diagnosis of early colorectal cancer. This test is much more useful in detecting prognosis other than early diagnostic phase, where the specificity is expected to be 65% of detecting diseases

Latest Reports:

ECG Equipment Market By End User Application (Hospitals, Ambulatory Care), Product (Resting ECG Systems, Stress ECG Systems, Holter Monitors), Lead Type (Single-Lead Devices, 3-6 LEAD Devices, 12 Lead Devices) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2022

Ostomy Drainage Bags Market By Product (Colostomy Bags, Urostomy Bags, Ileostomy Bags), By Usage (Single-Use (Disposable) Ostomy Bags, Multi-Use (Reusable) Ostomy Bags) – Growth, Share, Opportunities & Competitive Analysis, 2015 – 2022

Pain Management Devices Market By Product (Electrostimulaiton Devices, Radiofrequency Ablation Devices, Infusion Pumps, Neurostimulation Devices), By Applications (Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2022

About Us:

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Who we are

Credence Research is a worldwide firm, containing more than 15 research consultants and almost 100 research and information professionals.

Our customers mirror our worldwide nature. Around 45% are in Europe, 30% in the Americas, 13% in Asia Pacific and 12% in the Middle East and Africa.

Our firm is intended to work as one. We are a solitary global research organization united by a solid arrangement of qualities, concentrated on customer effect.

What we do

We serve customers at each level of their organization, in whatever limit we can be most helpful, whether as a trusted counsel to top management or as a hands-on mentor for forefront representatives. For each engagement, we collect a group with the most suitable experience and ability.

No matter the challenge, we concentrate on delivering functional and persevering results, and preparing our customers to develop and lead. We join forces with customers to place suggestions into practice. Our research specialist work straightforwardly with customers over long stretches to create workforce aptitudes, drive operational change, and apply new working strategies.


Name: Chris Smith

Designation: Global Sales Manager

E-mail: sales@credenceresearch.com

Ph: 1-800-361-8290

Web:  Credence Research


Release ID: 5804

About Chris Smith

Check Also

Global XLPE Insulated Cable Market Size, Share, Growth, Trends, Industry Analysis and Forecast 2017 By Acute Market Reports

This report studies sales (consumption) of XLPE Insulated Cable in United States market, focuses on ...